Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations of artemisinins, BCL-2 inhibitors, and kinase inhibitors for cancer treatment

Combinations of artemisinins, BCL-2 inhibitors, and kinase inhibitors for cancer treatment

US Patent 11554105 · Granted Jan 17, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and devices for multi-step cell purification and concentration2025
On-chip microfluidic processing of particles2022
Methods and devices for high throughput purification2022
Methods for preparing therapeutically active cells using microfluidics2022
Methods for preparing therapeutically active cells using microfluidics2021
High efficiency microfluidic purification of stem cells to improve transplants2021
Methods for preparing therapeutically active cells using microfluidics2021
Methods and devices for multi-step cell purification and concentration2021
Methods and devices for high throughput purification2020
Methods for preparing therapeutically active cells using microfluidics2020
Methods and devices for high throughput purification2019
Treatment of leukemia with artemisinin derivatives and combinations with other a2018